Controlled Gene Delivery Systems: Nanomaterials and Chemical Approaches

dc.authoridHamblin, Michael R/0000-0001-6431-4605
dc.authoridFatahi, Yousef/0000-0003-0374-2141
dc.authoridRabiee, Mohammad/0000-0003-1180-8729
dc.authoridKarimi/0000-0002-7977-3940
dc.authoridRabiee, Navid/0000-0002-6945-8541
dc.authoridNasseri, Behzad/0000-0003-3634-8327
dc.authorwosidHamblin, Mike/AAB-2511-2022
dc.authorwosidHamblin, Michael R/H-2758-2019
dc.authorwosidBagherzadeh, Mojtaba/ABC-2351-2020
dc.authorwosidFatahi, Yousef/S-6193-2016
dc.authorwosidRabiee, Mohammad/L-9865-2018
dc.authorwosidKarimi/F-8405-2017
dc.authorwosidRabiee, Navid/K-4407-2019
dc.contributor.authorAhmadi, Sepideh
dc.contributor.authorRabiee, Navid
dc.contributor.authorFatahi, Yousef
dc.contributor.authorBagherzadeh, Mojtaba
dc.contributor.authorGachpazan, Meysam
dc.contributor.authorBaheiraei, Nafiseh
dc.contributor.authorHamblin, Michael R.
dc.date.accessioned2024-07-05T15:38:36Z
dc.date.available2024-07-05T15:38:36Z
dc.date.issued2020
dc.departmentAtılım Universityen_US
dc.department-temp[Ahmadi, Sepideh] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Student Res Comm, Tehran 1985717443, Iran; [Ahmadi, Sepideh] Shahid Beheshti Univ Med Sci, Cellutar & Mol Biol Res Ctr, Tehran 1985717443, Iran; [Rabiee, Navid; Bagherzadeh, Mojtaba] Sharif Univ Technol, Dept Chem, Tehran 111553516, Iran; [Fatahi, Yousef] Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut Nanotechnol, Tehran 1417653911, Iran; [Fatahi, Yousef] Univ Tehran Med Sci, Fac Pharm, Nanotechnol Res Ctr, Tehran 1417653911, Iran; [Fatahi, Yousef] Universal Sci Educ & Res Network USERN, Tehran 1417653911, Iran; [Gachpazan, Meysam] Mashhad Univ Med Sci, Sch Med, Dept Med Genet & Mol Med, Mashhad 9177948564, Razavi Khorasan, Iran; [Baheiraei, Nafiseh] Tarbiat Modares Univ, Fac Med Sci, Dept Hematol, Tissue Engn & Appl Cell Sci Div, Tehran 1411713116, Iran; [Nasseri, Behzad] Hacettepe Univ, Chem Engn Dept, TR-06800 Ankara, Turkey; [Nasseri, Behzad] Hacettepe Univ, Bioengn Div, TR-06800 Ankara, Turkey; [Nasseri, Behzad] Atilim Univ, Dept Chem Engn & Appl Chem, TR-06830 Ankara, Turkey; [Karimi, Mahdi] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran 14665354, Iran; [Karimi, Mahdi] Iran Univ Med Sci, Fac Adv Technol Med, Dept Med Nanotechnol, Tehran 14665354, Iran; [Karimi, Mahdi] Iran Univ Med Sci, Oncopathol Res Ctr, Tehran 14665354, Iran; [Karimi, Mahdi] Univ Tehran Med Sci, Res Ctr Sci & Technol Med, Tehran 1417653911, Iran; [Karimi, Mahdi] Islamic Azad Univ, Appl Biotechnol Res Ctr, Tehran Med Sci, Tehran 1916893813, Iran; [Karimi, Mahdi; Hamblin, Michael R.] Harvard Med Sch, Wellman Ctr Photomed, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Webster, Thomas J.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Hamblin, Michael R.] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA; [Hamblin, Michael R.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USAen_US
dc.descriptionHamblin, Michael R/0000-0001-6431-4605; Fatahi, Yousef/0000-0003-0374-2141; Rabiee, Mohammad/0000-0003-1180-8729; Karimi/0000-0002-7977-3940; Rabiee, Navid/0000-0002-6945-8541; Nasseri, Behzad/0000-0003-3634-8327en_US
dc.description.abstractSuccessful gene therapy depends on the design of effective gene delivery systems. A gene delivery system is considered a powerful tool for the release of genetic material within cells resulting in a change in cell functions and protein production. The release of genes in a controlled manner by using appropriate carriers facilitates their release without side effects and increases the expression of genes at the released site. It is expected that significant changes in the combination of several genes and drugs can be provided by developing treatment systems sensitive to different stimuli such as redox potential, pH variations, temperature gradients, light irradiation, and enzyme activity. The most important advantages for the release of genes and stimuli-responsive therapeutics include delivering vectors locally, reducing side effects and causing no toxicity to distant tissues while at the same time reducing the immune response to the vectors. In this review, we aim to discuss different types of gene carriers involved in the controlled transfer of nucleic acids (non-viral inorganic and organic nanoparticles (NPs) and virus-like particles (VLPs)) as well as the simultaneous transfer of several genes and/or drugs into cells or different tissues, providing for an efficient and safe treatment of numerous diseases.en_US
dc.identifier.citation20
dc.identifier.doi10.1166/jbn.2020.2927
dc.identifier.endpage582en_US
dc.identifier.issn1550-7033
dc.identifier.issn1550-7041
dc.identifier.issue5en_US
dc.identifier.pmid32919478
dc.identifier.scopusqualityQ3
dc.identifier.startpage553en_US
dc.identifier.urihttps://doi.org/10.1166/jbn.2020.2927
dc.identifier.urihttps://hdl.handle.net/20.500.14411/3130
dc.identifier.volume16en_US
dc.identifier.wosWOS:000573055000001
dc.identifier.wosqualityQ3
dc.language.isoenen_US
dc.publisherAmer Scientific Publishersen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNanomedicineen_US
dc.subjectControlled Release of Genesen_US
dc.subjectGene Therapyen_US
dc.subjectNon-Viral Vectorsen_US
dc.subjectViral Vectorsen_US
dc.titleControlled Gene Delivery Systems: Nanomaterials and Chemical Approachesen_US
dc.typeReviewen_US
dspace.entity.typePublication

Files

Collections